Bing

SEARCH HISTORY

Keryx Biopharmaceuticals Inc. (KERX) experienced unusually high volume on May. 08, as the stock lost 4.21% to a closing price of $9.32. The stock saw 4.43 million shares trade hands over the course of the day on 18,285 trades. Given that the stock’s ...
Equities · 5/19/2015
Keryx Biopharmaceuticals (NASDAQ:KERX) is now one of the largest investments in Baupost Group’s equity portfolio, in which almost a half is represented by healthcare stocks. The stock gained around 19% since the beginning of the year, when Baupost ...
INSIDER MONKEY · 10/10/2014
Keryx Biopharmaceuticals (NASDAQ:KERX) released its earnings data on Monday. The company reported ($0.28) earnings per share for the quarter, beating the analysts’ consensus estimate of ($0.30) by $0.02, Stock Ratings Network.com reports. The …
wkrb13.com · 5/5/2015
More from Bing News
Keryx Biopharmaceuticals (NASDAQ:KERX) VP Brian Adams sold 4,320 shares of the stock in a transaction dated Wednesday, April 15th. The stock was sold at an average price of $12.40, for a total value of $53,568.00. Following the transaction, the vice ...
Ticker Report · 4/18/2015
Klarman has been increasing his investments in pharmaceutical stocks over the past years. KERX has had one of its recent drugs approved by the FDA. However, the FDA’s approval also came with safety warnings causing KERX stock to drop nearly 10% …
Guru Focus · 12/5/2014
Cory Kasimov has rated KERX 6 times since June 2013. Although he only has a 33% success rate recommending the stock, he has a +9.0% average return per KERX rating. Separately, Jonathan Aschoff of Brean Capital reiterated a Buy rating on Keryx …
investing.com · 5/5/2015
New York, NY – GDP INSIDER - 04/28/2014. This article discusses three companies: Keryx Biopharmaceuticals (NASDAQ:KERX), Wolverine World Wide, Inc. (NYSE:WWW) and La Quinta Holdings Inc (NYSE:LQ) Keryx Biopharmaceuticals (NASDAQ …
GDP Insider · 4/28/2015
(KERX) (F) Downgraded Sep 8, 2014 09:25 AM Pre-Open Stock Movers 9/8: (MGAM) (GCA) (HTZ) Higher; (HPTX) (KERX) (DGLY) Lower (more...) Sep 8, 2014 07:55 AM Roth Raises PT on Keryx Biophama (KERX) to $32 Following Ferric Citrate Approval …
StreetInsider · 5/15/2015
Keryx Biopharmaceuticals (NASDAQ:KERX) COO Greg Madison bought 6,380 shares of the company’s stock on the open market in a transaction that occurred on Friday, March 6th. The shares were purchased at an average price of $12.53 per share, for …
Intercooler · 3/11/2015
Even so, short-sellers have been piling into the stock ahead of the drug's Prescription Drug User Fee Act goal date of Sept. 7, 2014. KERX data by YCharts. With short-sellers now holding close to 23% of the float, it's important to consider four reasons ...
The Motley Fool · 6/7/2014